SPY424.57-0.69 -0.16%
DIA343.55-0.75 -0.22%
IXIC14,073.87-100.27 -0.71%

BRIEF-VBL Therapeutics Reports Q1 Revenue Of $185,000

05/11/2021 08:55
BRIEF-VBL Therapeutics Reports Q1 Revenue Of $185,000

- VBL Therapeutics VBLT.O:

  • VBL THERAPEUTICS REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

  • Q1 REVENUE $185,000 VERSUS REFINITIV IBES ESTIMATE OF $200,000

  • CASH POSITION EXPECTED TO FUND OPERATIONS UNTIL YEAR-END 2023

Source text for Eikon: ID:nGNX7xvpYL

Further company coverage: VBLT.O


(([email protected];))